Immunologic monitoring: implications for treatment of rejection.
Suthanthiran
M
M
Division of Nephrology, Department of Medicine, Weill Medical College of Cornell University, and Department of Transplantation Medicine, New York-Presbyterian Hospital, New York, USA.
D001707:Biopsy, Needle / Q000379:methods; D006084:Graft Rejection / Q000276:immunology / Q000473:pathology / Q000517:prevention & control*; D053804:Granzymes; D006801:Humans; D016753:Interleukin-10 / Q000235:genetics; D016030:Kidney Transplantation / Q000276:immunology* / Q000473:pathology; D015166:Monitoring, Immunologic / Q000379:methods*; D012333:RNA, Messenger / Q000032:analysis; D012697:Serine Endopeptidases / Q000235:genetics; D014158:Transcription, Genetic; D016212:Transforming Growth Factor beta / Q000235:genetics
D012333:RNA, Messenger; D016212:Transforming Growth Factor beta; D016753:Interleukin-10; C509213:GZMB protein, human; D053804:Granzymes; D012697:Serine Endopeptidases